東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Anticipatory ethics and the use of C...

Nestor, Michael W.

FindBook

Google Book

Amazon

博客來

Anticipatory ethics and the use of CRISPR in humans

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Anticipatory ethics and the use of CRISPR in humans/ by Michael W. Nestor, Richard L. Wilson.
作者:	Nestor, Michael W.
其他作者:	Wilson, Richard L.
出版者:	Cham :Springer International Publishing : : 2022.,
面頁冊數:	xix, 145 p. :ill. (chiefly col.), digital ;24 cm.
內容註:	Chapter 1: Brief Introduction to CRISPR Cas 9 -- Chapter 2: Introduction To Anticipatory Ethics -- Chapter 3: CRISPR, Phenomenology and Lived Experience -- Chapter 4: CRISPR and the Concept of Personhood -- Chapter 5: The use and access to CRISPR in historically socio-economically disadvantaged and marginalized communities -- Chapter 6: Future use of CRISPR: Gene Drive -- Chapter 7: Future use of CRISPR II: CRISPR Kill Switches -- Chapter 8: Domestic and International Regulation of CRISPR -- Chapter 9: Policy Recommendations with respect to CRISPR Germline Editing in Humans -- Chapter 10: Conclusions.
Contained By:	Springer Nature eBook
標題:	Gene editing - Moral and ethical aspects. -
電子資源:	https://doi.org/10.1007/978-3-030-98368-0
ISBN:	9783030983680

Anticipatory ethics and the use of CRISPR in humans
Nestor, Michael W.

Anticipatory ethics and the use of CRISPR in humans[electronic resource] /by Michael W. Nestor, Richard L. Wilson. - Cham :Springer International Publishing :2022. - xix, 145 p. :ill. (chiefly col.), digital ;24 cm.

Chapter 1: Brief Introduction to CRISPR Cas 9 -- Chapter 2: Introduction To Anticipatory Ethics -- Chapter 3: CRISPR, Phenomenology and Lived Experience -- Chapter 4: CRISPR and the Concept of Personhood -- Chapter 5: The use and access to CRISPR in historically socio-economically disadvantaged and marginalized communities -- Chapter 6: Future use of CRISPR: Gene Drive -- Chapter 7: Future use of CRISPR II: CRISPR Kill Switches -- Chapter 8: Domestic and International Regulation of CRISPR -- Chapter 9: Policy Recommendations with respect to CRISPR Germline Editing in Humans -- Chapter 10: Conclusions.

Can we move forward with the use of CRISPR in humans without a well-formed policy and ethical framework to support it? In this new book, neuroscientist Michael W. Nestor and philosopher Richard Wilson argue that the answer is a resounding "no." Does an ethical and policy program need to be restrictive concerning the use of CRISPR in humans? Nestor and Wilson argue that, although the future of gene editing in humans is inevitable using CRISPR technologies, the scientific, policy, ethics, and clinical communities must work together to provide the necessary frameworks to help CRISPR flourish as an essential tool to treat human disease. To achieve the most inclusive, equitable, and ethically sound use of CRISPR in humans, the scientific/policy/clinical community must involve the most comprehensive set of stakeholders possible, including the lay public. This book sets a framework for shared understanding and discussion across disciplines with an appeal to scientists and non-scientists alike. The authors urge all stakeholders to engage in active dialogue about the appropriate context for using CRISPR and other gene-editing technologies in humans. It provides policy analysis and recommendations for assuring the most inclusive, equitable, and ethically sound use of CRISPR in humans, exploring its positive potential to treat mental disorders and the potential to induce other cognitive enhancements.

ISBN: 9783030983680

Standard No.: 10.1007/978-3-030-98368-0doiSubjects--Topical Terms:

3597444
Gene editing
--Moral and ethical aspects.

LC Class. No.: QH438.7

Dewey Class. No.: 576.5

Anticipatory ethics and the use of CRISPR in humans
LDR:03027nmm a2200325 a 4500 001 2299702
003 DE-He213
005 20220524055537.0
006 m d
007 cr nn 008maaau
008 230324s2022 sz s 0 eng d
020 $a 9783030983680 $q (electronic bk.)
020 $a 9783030983673 $q (paper)
024 7 $a 10.1007/978-3-030-98368-0 $2 doi
035 $a 978-3-030-98368-0
040 $a GP $c GP
041 0 $a eng
050 4 $a QH438.7
072 7 $a TCB $2 bicssc
072 7 $a MED003040 $2 bisacsh
072 7 $a TCB $2 thema
082 0 4 $a 576.5 $2 23
090 $a QH438.7 $b .N468 2022
100 1 $a Nestor, Michael W. $3 3597442
245 1 0 $a Anticipatory ethics and the use of CRISPR in humans $h [electronic resource] / $c by Michael W. Nestor, Richard L. Wilson.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a xix, 145 p. : $b ill. (chiefly col.), digital ; $c 24 cm.
505 0 $a Chapter 1: Brief Introduction to CRISPR Cas 9 -- Chapter 2: Introduction To Anticipatory Ethics -- Chapter 3: CRISPR, Phenomenology and Lived Experience -- Chapter 4: CRISPR and the Concept of Personhood -- Chapter 5: The use and access to CRISPR in historically socio-economically disadvantaged and marginalized communities -- Chapter 6: Future use of CRISPR: Gene Drive -- Chapter 7: Future use of CRISPR II: CRISPR Kill Switches -- Chapter 8: Domestic and International Regulation of CRISPR -- Chapter 9: Policy Recommendations with respect to CRISPR Germline Editing in Humans -- Chapter 10: Conclusions.
520 $a Can we move forward with the use of CRISPR in humans without a well-formed policy and ethical framework to support it? In this new book, neuroscientist Michael W. Nestor and philosopher Richard Wilson argue that the answer is a resounding "no." Does an ethical and policy program need to be restrictive concerning the use of CRISPR in humans? Nestor and Wilson argue that, although the future of gene editing in humans is inevitable using CRISPR technologies, the scientific, policy, ethics, and clinical communities must work together to provide the necessary frameworks to help CRISPR flourish as an essential tool to treat human disease. To achieve the most inclusive, equitable, and ethically sound use of CRISPR in humans, the scientific/policy/clinical community must involve the most comprehensive set of stakeholders possible, including the lay public. This book sets a framework for shared understanding and discussion across disciplines with an appeal to scientists and non-scientists alike. The authors urge all stakeholders to engage in active dialogue about the appropriate context for using CRISPR and other gene-editing technologies in humans. It provides policy analysis and recommendations for assuring the most inclusive, equitable, and ethically sound use of CRISPR in humans, exploring its positive potential to treat mental disorders and the potential to induce other cognitive enhancements.
650 0 $a Gene editing $x Moral and ethical aspects. $3 3597444
650 0 $a Human genetics. $3 518846
650 0 $a CRISPR (Genetics) $3 3489201
650 1 4 $a Biotechnology. $3 571461
650 2 4 $a Medical Genetics. $3 3531302
700 1 $a Wilson, Richard L. $3 3597443
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-030-98368-0
950 $a Biomedical and Life Sciences (SpringerNature-11642)